Industry consolidation and cross-border deals are attractive opportunities for the firm in China, says Warburg managing director Min Fang.
Joint ventures with non-profits can aid firms in meeting the demands of a rapidly changing healthcare market, says Kimberly Smith, co-head of the national private equity practice at US attorneys Katten Muchin Rosenman.
In the second of a two-part series, Constitution Capital Partners’ Robert Hatch highlights that while healthcare has earned its reputation as a shelter sector, in the wake of a massive regulatory overhaul, potential hazards may exist.
In the first of a two-part series, Robert Hatch of Constitution Capital Partners explores some key takeaways for investors through analyzing over 1,000 healthcare buyouts, dating back to 1987.
Big pharma debt loads are spurring non-core divestment and creating opportunities for private equity carve-outs, GTCR managing director Sean Cunningham tells PHI.
Competition in healthcare deals in Asia is increasing along with demand in speciality healthcare, according to TPG Growth partner Matthew Hobart.
European LPs aren’t the only ones concerned with environmental, social, and corporate governance issues – these days, US LPs are increasingly keen to know what buyout giant KKR is doing to be part of the solution, the firm’s ESG director Elizabeth Seeger says.
Healthcare and M&A specialist Richard Zall, a partner at New York-based law firm Proskauer Rose, says PE fund managers need to develop networks of advisors with specialised knowledge if they want to outmanoeuvre strategic buyers.
Bill Bithoney, chief physician executive for The BDO Center for Healthcare Excellence & Innovation, analyses the external influences on price and the role investors need to take in assessing cost effectiveness.
Abraaj regional head for MENA, Ahmed Badreldin, talks about how to consolidate in the region, IPO sentiment and growth plans.